Clinical trial
Benefits and Risks Evaluation of Different Anti-platelet Strategies Beyond a 12-month Period Inpatients Receiving Sirolimus Drug-eluting Stent Implantation
NCT01233167 is registered in ClinicalTrials.gov with Sir Run Run Shaw Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Benefits and Risks Evaluation of Different Anti-platelet Strategies Beyond a 12-month Period Inpatients Receiving Sirolimus Drug-eluting Stent Implantation
- Lead sponsor
- Sir Run Run Shaw Hospital
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- August 31, 2011
- Completion date
- May 31, 2013
- Enrollment
- 5,232 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.